News
-
A study by Danish researchers published online November 25, 2013 by the Annals of Emergency Medicine found that intranasal fentanyl administered by ambulance workers prior to delivery of patients to the hospital appeared to be… Read more . . .
-
On the first day of the Inhalation Drug Symposium 2013 held November 8-9, 2013 in Nanjing, China, a group of five inhalation medicine specialists proposed the formation of a new organization to be called the… Read more . . .
-
Imperial Innovations Group has announced that it is contributing £4.25 million towards a total of £17 million ($27.5 million) in funding for a new inhaled drug discovery and development company called Pulmocide. Other investors in… Read more . . .
-
Copley Scientific has announced that it will introduce the new Child Alberta Idealised Throat for inhaler testing at Drug Delivery to the Lungs 24 along with its recently introduced TPK-R critical flow controller. The child… Read more . . .
-
Two inhalation combination products have been launched in Japan within a day of each other. Skyepharma has announced that its Japanese partner Kyorin launched a 56-inhalation version of the Flutiform fluticasone/formoterol MDI, and Sosei has… Read more . . .
-
Cornerstone Therapeutics has launched Bethkis tobramycin inhalation solution for the treatment of cystic fibrosis patients with P. aeruginosa infections in the US, the company said. According to Cornerstone, one dose of Bethkis contains 300 mg… Read more . . .
-
In accordance with their promise to provide open access to meeting materials, the organizers of Inhalation Asia 2013 have made all of the presentations from the meeting available on the meeting’s website. The presentations include… Read more . . .
-
Anyone who left the 2013 AAPS Annual Meeting after the first couple of days missed most of the highlights for OINDP specialists. . . . Read more Read more . . .
-
Aradigm has announced the appointment of Juergen Froehlich as Chief Medical Officer. Froehlich is formerly Head of Regulatory Affairs at Vertex Pharmaceuticals where he was responsible for regulatory submissions for Kalydeco. Both of Aradigm’s inhaled… Read more . . .
-
Particle Sciences has announced that it has been awarded a contract for development of an intranasal progesterone formulation for the treatment of traumatic brain injury by BHR Pharma, a subsidiary of Besins Healthcare. Besins announced… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.